The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | |||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | ||||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | FIGI | (to the nearest dollar) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
Alpine Immune Sciences | Common Stock | 02083G100 | 20,864,082 | 2,029,580 | SH | SOLE | 2,029,580 | 0 | 0 | |||
Ikena Oncology | Common Stock | 45175G108 | 14,754,247 | 2,249,123 | SH | SOLE | 2,249,123 | 0 | 0 | |||
Immunic Inc | Common Stock | 4525EP101 | 4,488,282 | 1,788,160 | SH | SOLE | 1,788,160 | 0 | 0 | |||
Kronos Bio | Common Stock | 50107A104 | 6,567,447 | 3,818,283 | SH | SOLE | 3,818,283 | 0 | 0 | |||
Morphic Holding | Common Stock | 61775R105 | 17,763,471 | 309,846 | SH | SOLE | 309,846 | 0 | 0 | |||
Nuvation Bio | Common Stock Class A | 67080N101 | 27,130,212 | 15,072,340 | SH | SOLE | 15,072,340 | 0 | 0 | |||
Replimune Group | Common Stock | 76029N106 | 69,690,627 | 3,001,319 | SH | SOLE | 3,001,319 | 0 | 0 | |||
Sana Biotechnology, Inc. | Common Stock | 799566104 | 5,028,750 | 843,750 | SH | SOLE | 843,750 | 0 | 0 | |||
Senti Biosciences, Inc. | Common Stock | 81726A100 | 122,762 | 195,792 | SH | SOLE | 195,792 | 0 | 0 | |||
Spruce Biosciences | Common Stock | 85209E109 | 4,646,197 | 2,161,022 | SH | SOLE | 2,161,022 | 0 | 0 | |||
Syros Pharmaceuticals | Common Stock | 87184Q206 | 791,500 | 251,270 | SH | SOLE | 251,270 | 0 | 0 | |||
Theseus Pharmaceuticals | Common Stock | 88369M101 | 6,638,099 | 711,479 | SH | SOLE | 711,479 | 0 | 0 |